Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
OPERATING ACTIVITIES
Net income (loss)	$ 17,377,614	$ (11,178,239)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	28,801	28,195
Stock-based compensation	3,672,420	1,272,611
Loss from change in fair value of promissory notes	1,304,000	993,000
(Gain) loss from change in fair value of warrant liability	(40,272,880)	53,342
Loss (income) on equity method investment	33,295	(2,548)
Changes in operating assets and liabilities:
Inventory	(3,109,397)
Prepaid expenses and other current assets	5,633,097	(2,445,363)
Operating lease liabilities	(12,071)
Accounts payable	4,224,022	(3,094,197)
Accrued expenses	153,764	1,341,030
Net cash used in operating activities	(10,967,335)	(13,032,169)
FINANCING ACTIVITIES
Proceeds from the sale of common stock, net of issuance costs	1,742,373
Payments of finance lease obligations		(3,183)
Net cash provided by (used in) financing activities	1,742,373	(3,183)
Net decrease in cash and cash equivalents	(9,224,962)	(13,035,352)
Cash and cash equivalents at beginning of period	14,927,538	23,391,982
Cash and cash equivalents at end of period	5,702,576	$ 10,356,630
Supplemental schedule of non-cash financing activities:
Reclassification of deferred offering costs against ATM proceeds	$ 6,331